Scientists at Mizzou have identified two small molecules, agmatine and thiamine, that could both reveal and fight glaucoma.

Avisi Technologies has released positive 12-month clinical data on the VisiPlate Aqueous Shunt from the VITA Trial. The VITA ...

A research team at the University of Missouri has made a discovery that could transform how glaucoma is detected and treated. Glaucoma, a major cause ...

Avisi Technologies, Inc., an ophthalmic medical device company advancing novel, sight-saving technologies, presented positive twelve-month clinical data on VisiPlate® Aqueous Shunt from the VITA Trial ...

With the bulk of its revenue now derived from the US, Adelaide-based glaucoma device maker Nova Eye Medical (ASX:EYE) would ...

Sight Sciences’ management is scheduled to present at the Stifel 2025 Healthcare Conference on Tuesday, November 11, 2025 at 8:20 am PT / 11:20 am ET. Sight Sciences’ management is scheduled to ...

Patients with glaucoma experience earlier onset of presbyopia than those without the disease, according to research published in Clinical and Experimental Optometry. The findings suggest that glaucoma ...

Background/Aims The neuroprotective effect of nicotinamide (NAM) supplementation has been demonstrated in both animal models ...

U.S. Glaucoma net sales reached $80.8 million, with iDose TR contributing approximately $40 million. International Glaucoma net sales were $29.4 million, and Corneal Health franchise net sales totaled ...

Q3 2025 Earnings Call October 29, 2025 4:30 PM EDTCompany ParticipantsChristopher Lewis - Vice President of Investor ...

What are the signs that show I need cataract surgery? "There are several key signs that someone may need cataract surgery," ...

Through 24 months, scleral bio-reinforced cyclodialysis combined with cataract surgery lowered IOP by enhancing uveoscleral ...